Reducing TNF receptor 2+ regulatory T cells via the combined action of azacitidine and the HDAC inhibitor, panobinostat for clinical benefit in acute myeloid leukemia patients (Q43501191)
Jump to navigation
Jump to search
scientific article published on 2 December 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Reducing TNF receptor 2+ regulatory T cells via the combined action of azacitidine and the HDAC inhibitor, panobinostat for clinical benefit in acute myeloid leukemia patients |
scientific article published on 2 December 2013 |
Statements
1 reference
Reducing TNF receptor 2+ regulatory T cells via the combined action of azacitidine and the HDAC inhibitor, panobinostat for clinical benefit in acute myeloid leukemia patients (English)
1 reference
Magdalena Plebanski
1 reference
Chindu Govindaraj
1 reference
Peter Tan
1 reference
Patricia Walker
1 reference
Andrew Wei
1 reference
Andrew Spencer
1 reference
2 December 2013
1 reference
1 reference
20
1 reference
3
1 reference
724-735
1 reference
Identifiers
1 reference
1 reference